Oxford Asset Management’s Purple Biotech PPBT Stock Holding History

Oxford Asset Management’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6	Closed	-$29K	–	1837
2017 Q4	$29K	Buy	+6	New	+$26.8K	﹤0.01%	1580

Other funds holding PPBT

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Oxford Asset Management's PPBT Position: Q1 2018 in Review

Oxford Asset Management sold out of Purple Biotech (PPBT) in Q1 2018, closing a stake of 6 shares — an estimated $29K sold.

Oxford Asset Management first reported a position in PPBT in Q4 2017 and held it in 1 quarter. The position peaked at $29K in Q4 2017. 3 funds tracked by Wall St. Rank hold PPBT as of Q1 2018.

Oxford Asset Management reported no remaining Purple Biotech position as of Q1 2018 after selling out during the quarter.
Oxford Asset Management sold 6 Purple Biotech shares in Q1 2018, an estimated $29K.
Oxford Asset Management first reported a position in Purple Biotech in Q4 2017 and held it in 1 quarter.
Oxford Asset Management's Purple Biotech position peaked at $29K in Q4 2017.
3 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.